

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 8.72720291 |
| 2 | cAMP catabolic process (GO:0006198) | 8.31192998 |
| 3 | prenylation (GO:0097354) | 7.91626325 |
| 4 | protein prenylation (GO:0018342) | 7.91626325 |
| 5 | regulation of centriole replication (GO:0046599) | 7.79229809 |
| 6 | cellular response to epinephrine stimulus (GO:0071872) | 7.60158032 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 7.55167268 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55167268 |
| 9 | negative regulation of complement activation (GO:0045916) | 7.48504787 |
| 10 | citrulline biosynthetic process (GO:0019240) | 7.41552847 |
| 11 | midgut development (GO:0007494) | 7.32010815 |
| 12 | cyclic nucleotide catabolic process (GO:0009214) | 7.27064830 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.20105604 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20105604 |
| 15 | cilium or flagellum-dependent cell motility (GO:0001539) | 7.14049828 |
| 16 | negative regulation of humoral immune response (GO:0002921) | 7.05447613 |
| 17 | pericardium development (GO:0060039) | 7.02523030 |
| 18 | hepatocyte differentiation (GO:0070365) | 6.88547380 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 6.78835985 |
| 20 | positive regulation of odontogenesis (GO:0042482) | 6.69886653 |
| 21 | regulation of cardiac muscle cell contraction (GO:0086004) | 6.68898414 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 6.44426586 |
| 23 | response to epinephrine (GO:0071871) | 6.40550752 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.28544640 |
| 25 | axonemal dynein complex assembly (GO:0070286) | 6.24763028 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 6.13739188 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 6.13739188 |
| 28 | tryptophan catabolic process (GO:0006569) | 6.13739188 |
| 29 | negative regulation of B cell mediated immunity (GO:0002713) | 6.04446191 |
| 30 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 6.04446191 |
| 31 | kynurenine metabolic process (GO:0070189) | 6.02866672 |
| 32 | bile acid biosynthetic process (GO:0006699) | 5.93046794 |
| 33 | tryptophan metabolic process (GO:0006568) | 5.77517743 |
| 34 | glyoxylate metabolic process (GO:0046487) | 5.75755464 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 5.74736577 |
| 36 | regulation of interleukin-5 production (GO:0032674) | 5.71370166 |
| 37 | Rap protein signal transduction (GO:0032486) | 5.71246778 |
| 38 | urea cycle (GO:0000050) | 5.70529730 |
| 39 | urea metabolic process (GO:0019627) | 5.70529730 |
| 40 | alpha-linolenic acid metabolic process (GO:0036109) | 5.64737319 |
| 41 | regulation of protein activation cascade (GO:2000257) | 5.55855923 |
| 42 | complement activation, alternative pathway (GO:0006957) | 5.54994673 |
| 43 | regulation of fibrinolysis (GO:0051917) | 5.54351525 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51908166 |
| 45 | protein carboxylation (GO:0018214) | 5.47859634 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.47859634 |
| 47 | iron ion import (GO:0097286) | 5.43918893 |
| 48 | cysteine metabolic process (GO:0006534) | 5.37409510 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 5.28423161 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 5.23852293 |
| 51 | citrulline metabolic process (GO:0000052) | 5.23092243 |
| 52 | regulation of complement activation (GO:0030449) | 5.16382623 |
| 53 | atrioventricular valve morphogenesis (GO:0003181) | 5.15136436 |
| 54 | regulation of actin filament-based movement (GO:1903115) | 5.14459440 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 5.13693913 |
| 56 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 5.13043934 |
| 57 | bile acid metabolic process (GO:0008206) | 5.11518047 |
| 58 | motile cilium assembly (GO:0044458) | 5.08386430 |
| 59 | monoubiquitinated protein deubiquitination (GO:0035520) | 5.00375753 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.99619914 |
| 61 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.99599667 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 4.92470981 |
| 63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86410998 |
| 64 | reverse cholesterol transport (GO:0043691) | 4.85074448 |
| 65 | cilium movement (GO:0003341) | 4.84937583 |
| 66 | homocysteine metabolic process (GO:0050667) | 4.82868736 |
| 67 | regulation of cholesterol esterification (GO:0010872) | 4.80486975 |
| 68 | S-adenosylmethionine metabolic process (GO:0046500) | 4.79969590 |
| 69 | tyrosine metabolic process (GO:0006570) | 4.78774997 |
| 70 | establishment of apical/basal cell polarity (GO:0035089) | 4.78306806 |
| 71 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 4.78084742 |
| 72 | macromolecular complex remodeling (GO:0034367) | 4.77958764 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 4.77958764 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 4.77958764 |
| 75 | regulation of centrosome duplication (GO:0010824) | 4.76919308 |
| 76 | response to growth hormone (GO:0060416) | 4.75385575 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 4.73897387 |
| 78 | alpha-amino acid catabolic process (GO:1901606) | 4.63589193 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 4.62136551 |
| 80 | acylglycerol homeostasis (GO:0055090) | 4.60478605 |
| 81 | triglyceride homeostasis (GO:0070328) | 4.60478605 |
| 82 | lysine catabolic process (GO:0006554) | 4.57132726 |
| 83 | lysine metabolic process (GO:0006553) | 4.57132726 |
| 84 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.51874931 |
| 85 | regulation of glucocorticoid metabolic process (GO:0031943) | 4.50824124 |
| 86 | negative regulation of sterol transport (GO:0032372) | 4.50668018 |
| 87 | negative regulation of cholesterol transport (GO:0032375) | 4.50668018 |
| 88 | phospholipid efflux (GO:0033700) | 4.49752511 |
| 89 | positive regulation of p38MAPK cascade (GO:1900745) | 4.47898463 |
| 90 | bile acid and bile salt transport (GO:0015721) | 4.47204872 |
| 91 | negative regulation of hormone metabolic process (GO:0032351) | 4.46430657 |
| 92 | cellular ketone body metabolic process (GO:0046950) | 4.46068476 |
| 93 | glycine metabolic process (GO:0006544) | 4.43855182 |
| 94 | response to dexamethasone (GO:0071548) | 4.42275463 |
| 95 | imidazole-containing compound metabolic process (GO:0052803) | 4.39857160 |
| 96 | plasma lipoprotein particle clearance (GO:0034381) | 4.39088086 |
| 97 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.36406404 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 4.34388362 |
| 99 | coenzyme catabolic process (GO:0009109) | 4.32542309 |
| 100 | cellular glucuronidation (GO:0052695) | 4.28915940 |
| 101 | glutamate metabolic process (GO:0006536) | 4.25960643 |
| 102 | cholesterol efflux (GO:0033344) | 4.25722570 |
| 103 | cellular amino acid catabolic process (GO:0009063) | 4.25272236 |
| 104 | amine catabolic process (GO:0009310) | 4.25239871 |
| 105 | cellular biogenic amine catabolic process (GO:0042402) | 4.25239871 |
| 106 | adrenergic receptor signaling pathway (GO:0071875) | 4.24812578 |
| 107 | nuclear pore complex assembly (GO:0051292) | 4.22237284 |
| 108 | serine family amino acid metabolic process (GO:0009069) | 4.17853017 |
| 109 | response to food (GO:0032094) | 4.16186723 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 4.12566368 |
| 111 | benzene-containing compound metabolic process (GO:0042537) | 4.09956448 |
| 112 | fibrinolysis (GO:0042730) | 4.09927561 |
| 113 | positive regulation of osteoblast proliferation (GO:0033690) | 4.07988403 |
| 114 | ethanol oxidation (GO:0006069) | 4.07340683 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03938552 |
| 116 | cellular modified amino acid catabolic process (GO:0042219) | 4.03501663 |
| 117 | establishment of monopolar cell polarity (GO:0061162) | 4.02901650 |
| 118 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.02901650 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 4.02072634 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 4.01849496 |
| 121 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.98502795 |
| 122 | arginine metabolic process (GO:0006525) | 3.97323078 |
| 123 | aldehyde catabolic process (GO:0046185) | 3.95856684 |
| 124 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94956508 |
| 125 | drug catabolic process (GO:0042737) | 3.90593620 |
| 126 | positive regulation of vascular permeability (GO:0043117) | 3.90029161 |
| 127 | long term synaptic depression (GO:0060292) | 3.88358705 |
| 128 | ketone body metabolic process (GO:1902224) | 3.86083191 |
| 129 | complement activation, classical pathway (GO:0006958) | 3.85363850 |
| 130 | epithelial cilium movement (GO:0003351) | 3.84362741 |
| 131 | complement activation (GO:0006956) | 3.83876899 |
| 132 | protein activation cascade (GO:0072376) | 3.83748890 |
| 133 | phospholipid homeostasis (GO:0055091) | 3.83021364 |
| 134 | regulation of centrosome cycle (GO:0046605) | 3.81815527 |
| 135 | uronic acid metabolic process (GO:0006063) | 3.80252784 |
| 136 | glucuronate metabolic process (GO:0019585) | 3.80252784 |
| 137 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78618962 |
| 138 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78257322 |
| 139 | cofactor catabolic process (GO:0051187) | 3.77701915 |
| 140 | cholesterol homeostasis (GO:0042632) | 3.76584914 |
| 141 | positive regulation of lipid catabolic process (GO:0050996) | 3.74014775 |
| 142 | cornea development in camera-type eye (GO:0061303) | 3.72394098 |
| 143 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72265332 |
| 144 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72265332 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 3.72245720 |
| 146 | organic acid catabolic process (GO:0016054) | 3.71668305 |
| 147 | carboxylic acid catabolic process (GO:0046395) | 3.71668305 |
| 148 | negative regulation of protein activation cascade (GO:2000258) | 3.70508780 |
| 149 | sterol homeostasis (GO:0055092) | 3.70327710 |
| 150 | negative regulation of lipase activity (GO:0060192) | 3.66998103 |
| 151 | cytolysis (GO:0019835) | 3.64085174 |
| 152 | plasma lipoprotein particle organization (GO:0071827) | 3.63880569 |
| 153 | acetyl-CoA metabolic process (GO:0006084) | 3.63853419 |
| 154 | short-chain fatty acid metabolic process (GO:0046459) | 3.62969576 |
| 155 | acute-phase response (GO:0006953) | 3.61876983 |
| 156 | protein-lipid complex assembly (GO:0065005) | 3.60199238 |
| 157 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.58349965 |
| 158 | protein destabilization (GO:0031648) | 3.56897772 |
| 159 | polarized epithelial cell differentiation (GO:0030859) | 3.51731181 |
| 160 | dorsal/ventral axis specification (GO:0009950) | 3.50788013 |
| 161 | positive regulation of astrocyte differentiation (GO:0048711) | 3.49994228 |
| 162 | establishment of endothelial barrier (GO:0061028) | 3.48304853 |
| 163 | renal absorption (GO:0070293) | 3.43330673 |
| 164 | nuclear pore organization (GO:0006999) | 3.39253462 |
| 165 | axoneme assembly (GO:0035082) | 3.38290172 |
| 166 | cAMP metabolic process (GO:0046058) | 3.35592797 |
| 167 | cAMP-mediated signaling (GO:0019933) | 3.26200112 |
| 168 | negative regulation of gluconeogenesis (GO:0045721) | 3.25747446 |
| 169 | embryonic body morphogenesis (GO:0010172) | 3.19305257 |
| 170 | endocardial cushion morphogenesis (GO:0003203) | 3.18795716 |
| 171 | regulation of p38MAPK cascade (GO:1900744) | 3.17540611 |
| 172 | pore complex assembly (GO:0046931) | 3.15550208 |
| 173 | glycogen catabolic process (GO:0005980) | 3.08615918 |
| 174 | sulfur amino acid metabolic process (GO:0000096) | 3.08196898 |
| 175 | cellular response to catecholamine stimulus (GO:0071870) | 3.03846461 |
| 176 | cellular response to monoamine stimulus (GO:0071868) | 3.03846461 |
| 177 | nodal signaling pathway (GO:0038092) | 3.02555359 |
| 178 | negative regulation of heart contraction (GO:0045822) | 2.95232254 |
| 179 | glucan catabolic process (GO:0009251) | 2.91743733 |
| 180 | import into cell (GO:0098657) | 2.90330798 |
| 181 | positive regulation of heart rate (GO:0010460) | 2.89453535 |
| 182 | cellular response to cAMP (GO:0071320) | 2.79500734 |
| 183 | triglyceride catabolic process (GO:0019433) | 2.78378691 |
| 184 | cellular polysaccharide catabolic process (GO:0044247) | 2.74652483 |
| 185 | glutamine metabolic process (GO:0006541) | 2.70488150 |
| 186 | cell proliferation involved in kidney development (GO:0072111) | 2.70074402 |
| 187 | keratinocyte development (GO:0003334) | 2.69599581 |
| 188 | ER overload response (GO:0006983) | 2.68111609 |
| 189 | centriole assembly (GO:0098534) | 2.67976793 |
| 190 | response to laminar fluid shear stress (GO:0034616) | 2.67407936 |
| 191 | response to catecholamine (GO:0071869) | 2.63864948 |
| 192 | response to monoamine (GO:0071867) | 2.63864948 |
| 193 | cGMP-mediated signaling (GO:0019934) | 2.63797906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38453709 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16843111 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.03276781 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52443633 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30639589 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.15363750 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75631141 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09753359 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06473828 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.58504757 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.13230295 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.54456701 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.29512635 |
| 14 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.18422968 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07821347 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02308758 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9978307 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94724240 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89807774 |
| 20 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.71278092 |
| 21 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.70097610 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64663680 |
| 23 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.58842711 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57731508 |
| 25 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.56112642 |
| 26 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.54847057 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54361505 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54016573 |
| 29 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.51726299 |
| 30 | NFYB_21822215_ChIP-Seq_K562_Human | 1.49383017 |
| 31 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.47708724 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.47547084 |
| 33 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.46882621 |
| 34 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.45587349 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43922891 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41819291 |
| 37 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40893705 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36063709 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34400914 |
| 40 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.31965518 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30691698 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27044972 |
| 43 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26002573 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24381384 |
| 45 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.22266757 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.20692657 |
| 47 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19041821 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18583295 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18581088 |
| 50 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.17780746 |
| 51 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16798986 |
| 52 | TBL1_22424771_ChIP-Seq_293T_Human | 1.16584481 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15213039 |
| 54 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.14536242 |
| 55 | NFYA_21822215_ChIP-Seq_K562_Human | 1.13972491 |
| 56 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13929917 |
| 57 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10818284 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.10021292 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06475688 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06307275 |
| 61 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04980385 |
| 62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04980385 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03341836 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02842019 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02625687 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01812999 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01785036 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99771180 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99382504 |
| 70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98551766 |
| 71 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97291889 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 0.95354167 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94766257 |
| 74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94659954 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94487826 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94032105 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 0.92262160 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91720461 |
| 79 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.91704713 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91652689 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91414468 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87902084 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86138830 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.85804093 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85759815 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85672720 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85643508 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84567036 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84228445 |
| 90 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.82853218 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81924255 |
| 92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80273816 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80228339 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79986048 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79580354 |
| 96 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.79373665 |
| 97 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.78368399 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75715757 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75566934 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75326729 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75073733 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74987282 |
| 103 | MYB_26560356_Chip-Seq_TH2_Human | 0.74435030 |
| 104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74222114 |
| 105 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73789270 |
| 106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.73547607 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72744743 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72677002 |
| 109 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72583721 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.71447097 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71430394 |
| 112 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71078088 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.70383067 |
| 114 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.70007037 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69494620 |
| 116 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.69318373 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69135916 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68994448 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66725667 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65797929 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65797929 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64885986 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61508001 |
| 124 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59347993 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58543052 |
| 126 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57369172 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57043375 |
| 128 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56887941 |
| 129 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56651420 |
| 130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54089525 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52597844 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51984350 |
| 133 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.51536526 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51013047 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50452020 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50248553 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50078342 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49644882 |
| 139 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48760521 |
| 140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48655824 |
| 141 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48471347 |
| 142 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48271464 |
| 143 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45926808 |
| 144 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45663085 |
| 145 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45638587 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45580858 |
| 147 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45484526 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45290485 |
| 149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44980977 |
| 150 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44449420 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43020908 |
| 152 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42680381 |
| 153 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41856632 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41633726 |
| 155 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41401417 |
| 156 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41390204 |
| 157 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41263703 |
| 158 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40858018 |
| 159 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40770607 |
| 160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40598120 |
| 161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38933858 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38605807 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38396388 |
| 164 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37819411 |
| 165 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37134061 |
| 166 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36473335 |
| 167 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36421192 |
| 168 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35463557 |
| 169 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.34572962 |
| 170 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34204254 |
| 171 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.33958344 |
| 172 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33554089 |
| 173 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33392204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37730321 |
| 2 | MP0005360_urolithiasis | 7.72264474 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.26585348 |
| 4 | MP0005365_abnormal_bile_salt | 6.20495261 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19085310 |
| 6 | MP0008057_abnormal_DNA_replication | 4.72791636 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.30108512 |
| 8 | MP0003252_abnormal_bile_duct | 3.96395822 |
| 9 | MP0002009_preneoplasia | 3.96377623 |
| 10 | MP0000569_abnormal_digit_pigmentation | 3.84594542 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.65690636 |
| 12 | MP0009840_abnormal_foam_cell | 3.28892035 |
| 13 | MP0000003_abnormal_adipose_tissue | 3.18633318 |
| 14 | MP0003195_calcinosis | 2.91051835 |
| 15 | MP0005332_abnormal_amino_acid | 2.77860290 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.61331373 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.57286891 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.50587760 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.39014673 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.38490675 |
| 21 | MP0008058_abnormal_DNA_repair | 2.27083695 |
| 22 | * MP0000609_abnormal_liver_physiology | 2.18140498 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.16353429 |
| 24 | MP0003077_abnormal_cell_cycle | 2.13651236 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.13000859 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.07100873 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.99444260 |
| 28 | MP0010094_abnormal_chromosome_stability | 1.94046823 |
| 29 | * MP0005083_abnormal_biliary_tract | 1.93466543 |
| 30 | MP0003868_abnormal_feces_composition | 1.93216219 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.87875232 |
| 32 | MP0003693_abnormal_embryo_hatching | 1.79151252 |
| 33 | * MP0005319_abnormal_enzyme/_coenzyme | 1.78048945 |
| 34 | MP0008961_abnormal_basal_metabolism | 1.70788896 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.67294106 |
| 36 | MP0001764_abnormal_homeostasis | 1.66136375 |
| 37 | MP0005171_absent_coat_pigmentation | 1.64458491 |
| 38 | MP0009697_abnormal_copulation | 1.62183757 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.58598765 |
| 40 | MP0005253_abnormal_eye_physiology | 1.55939051 |
| 41 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.49878598 |
| 42 | MP0002160_abnormal_reproductive_system | 1.46892783 |
| 43 | MP0004133_heterotaxia | 1.46468180 |
| 44 | MP0003136_yellow_coat_color | 1.46429777 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.43585808 |
| 46 | MP0004957_abnormal_blastocyst_morpholog | 1.43563365 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.42163668 |
| 48 | MP0003011_delayed_dark_adaptation | 1.41688857 |
| 49 | MP0005451_abnormal_body_composition | 1.40918676 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.40537530 |
| 51 | MP0003984_embryonic_growth_retardation | 1.39759470 |
| 52 | MP0003786_premature_aging | 1.37356083 |
| 53 | MP0004233_abnormal_muscle_weight | 1.35931263 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.28915385 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.28723040 |
| 56 | MP0003186_abnormal_redox_activity | 1.24753262 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.23341037 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.22928461 |
| 59 | MP0004043_abnormal_pH_regulation | 1.20545265 |
| 60 | MP0000383_abnormal_hair_follicle | 1.19857930 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.19345630 |
| 62 | * MP0000598_abnormal_liver_morphology | 1.18479200 |
| 63 | MP0005375_adipose_tissue_phenotype | 1.16123043 |
| 64 | MP0005647_abnormal_sex_gland | 1.15664174 |
| 65 | MP0000604_amyloidosis | 1.14322250 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.13649346 |
| 67 | MP0002254_reproductive_system_inflammat | 1.12298419 |
| 68 | MP0005380_embryogenesis_phenotype | 1.09206741 |
| 69 | MP0001672_abnormal_embryogenesis/_devel | 1.09206741 |
| 70 | MP0009764_decreased_sensitivity_to | 1.08978499 |
| 71 | MP0002086_abnormal_extraembryonic_tissu | 1.08381589 |
| 72 | MP0006138_congestive_heart_failure | 1.04302663 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.03186237 |
| 74 | * MP0009763_increased_sensitivity_to | 1.01563309 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 1.00368650 |
| 76 | MP0010678_abnormal_skin_adnexa | 1.00120035 |
| 77 | MP0003699_abnormal_female_reproductive | 0.98409244 |
| 78 | MP0001929_abnormal_gametogenesis | 0.98072519 |
| 79 | MP0005391_vision/eye_phenotype | 0.97935476 |
| 80 | MP0009703_decreased_birth_body | 0.97512965 |
| 81 | MP0010307_abnormal_tumor_latency | 0.95801696 |
| 82 | MP0003111_abnormal_nucleus_morphology | 0.95427571 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.93377899 |
| 84 | MP0002006_tumorigenesis | 0.93062131 |
| 85 | MP0002697_abnormal_eye_size | 0.91817012 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.91001627 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.88124700 |
| 88 | * MP0008469_abnormal_protein_level | 0.88077918 |
| 89 | * MP0009642_abnormal_blood_homeostasis | 0.87662646 |
| 90 | MP0003303_peritoneal_inflammation | 0.86229441 |
| 91 | MP0005408_hypopigmentation | 0.86044697 |
| 92 | MP0005670_abnormal_white_adipose | 0.83160077 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.81182188 |
| 94 | MP0002111_abnormal_tail_morphology | 0.81006637 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.79971187 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.79754049 |
| 97 | MP0004147_increased_porphyrin_level | 0.79657239 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.79028088 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.78168349 |
| 100 | MP0001661_extended_life_span | 0.77970590 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.76062678 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.75235557 |
| 103 | MP0002971_abnormal_brown_adipose | 0.75000311 |
| 104 | MP0003091_abnormal_cell_migration | 0.73672402 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.73009147 |
| 106 | MP0004130_abnormal_muscle_cell | 0.72364188 |
| 107 | MP0009278_abnormal_bone_marrow | 0.71678107 |
| 108 | MP0003690_abnormal_glial_cell | 0.71628129 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.71095390 |
| 110 | MP0005334_abnormal_fat_pad | 0.70647392 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.70494979 |
| 112 | MP0005410_abnormal_fertilization | 0.69599005 |
| 113 | MP0006072_abnormal_retinal_apoptosis | 0.69298356 |
| 114 | MP0009053_abnormal_anal_canal | 0.68378664 |
| 115 | MP0004197_abnormal_fetal_growth/weight/ | 0.67873112 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.67227373 |
| 117 | MP0003329_amyloid_beta_deposits | 0.64716750 |
| 118 | MP0005266_abnormal_metabolism | 0.63948612 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.62535314 |
| 120 | MP0001340_abnormal_eyelid_morphology | 0.62072657 |
| 121 | MP0000358_abnormal_cell_content/ | 0.61789484 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.60065458 |
| 123 | MP0001756_abnormal_urination | 0.58870236 |
| 124 | MP0005448_abnormal_energy_balance | 0.57665437 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.57643571 |
| 126 | * MP0005535_abnormal_body_temperature | 0.55908765 |
| 127 | MP0005395_other_phenotype | 0.51895892 |
| 128 | MP0002822_catalepsy | 0.48735270 |
| 129 | MP0003436_decreased_susceptibility_to | 0.48552217 |
| 130 | MP0002928_abnormal_bile_duct | 0.47962065 |
| 131 | * MP0005220_abnormal_exocrine_pancreas | 0.47312688 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.47212509 |
| 133 | MP0003724_increased_susceptibility_to | 0.46870956 |
| 134 | MP0003718_maternal_effect | 0.46788732 |
| 135 | MP0008874_decreased_physiological_sensi | 0.46159548 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.46096089 |
| 137 | MP0008873_increased_physiological_sensi | 0.45070674 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.43220955 |
| 139 | MP0005248_abnormal_Harderian_gland | 0.42169729 |
| 140 | MP0003075_altered_response_to | 0.41838412 |
| 141 | MP0003953_abnormal_hormone_level | 0.41267929 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.39486590 |
| 143 | MP0005166_decreased_susceptibility_to | 0.38783288 |
| 144 | MP0000579_abnormal_nail_morphology | 0.38142802 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.37887299 |
| 146 | MP0009672_abnormal_birth_weight | 0.37490938 |
| 147 | MP0008872_abnormal_physiological_respon | 0.36312477 |
| 148 | MP0004381_abnormal_hair_follicle | 0.35247324 |
| 149 | MP0000249_abnormal_blood_vessel | 0.34109613 |
| 150 | MP0009384_cardiac_valve_regurgitation | 0.34108842 |
| 151 | MP0002168_other_aberrant_phenotype | 0.33738411 |
| 152 | MP0004883_abnormal_blood_vessel | 0.33437546 |
| 153 | MP0009115_abnormal_fat_cell | 0.33418740 |
| 154 | MP0001853_heart_inflammation | 0.32870671 |
| 155 | MP0006082_CNS_inflammation | 0.32437383 |
| 156 | MP0001243_abnormal_dermal_layer | 0.32427520 |
| 157 | MP0000230_abnormal_systemic_arterial | 0.31265883 |
| 158 | MP0002970_abnormal_white_adipose | 0.31196895 |
| 159 | MP0002796_impaired_skin_barrier | 0.30950054 |
| 160 | MP0001881_abnormal_mammary_gland | 0.28762547 |
| 161 | MP0005164_abnormal_response_to | 0.26731006 |
| 162 | * MP0001845_abnormal_inflammatory_respons | 0.26364829 |
| 163 | MP0002132_abnormal_respiratory_system | 0.24813544 |
| 164 | MP0002060_abnormal_skin_morphology | 0.24459153 |
| 165 | MP0000427_abnormal_hair_cycle | 0.24210176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.56877622 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.34484429 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.30119678 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.74508410 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63461872 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.47882568 |
| 7 | Fair hair (HP:0002286) | 6.30567231 |
| 8 | Xanthomatosis (HP:0000991) | 6.29641877 |
| 9 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.18728534 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 5.96566732 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.96566732 |
| 12 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.85230449 |
| 13 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.85230449 |
| 14 | Abnormal ciliary motility (HP:0012262) | 5.64633589 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.63385927 |
| 16 | Complement deficiency (HP:0004431) | 5.56046941 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 5.53164449 |
| 18 | Abnormality of the nasal septum (HP:0000419) | 5.33125350 |
| 19 | Cerebellar dysplasia (HP:0007033) | 5.29166766 |
| 20 | Rhinitis (HP:0012384) | 5.10527531 |
| 21 | Joint hemorrhage (HP:0005261) | 4.92753691 |
| 22 | Mild short stature (HP:0003502) | 4.86273222 |
| 23 | Hypolipoproteinemia (HP:0010981) | 4.84763557 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.71321179 |
| 25 | Epidermoid cyst (HP:0200040) | 4.59775977 |
| 26 | Hyperammonemia (HP:0001987) | 4.56902389 |
| 27 | Generalized hypopigmentation of hair (HP:0011358) | 4.47020973 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43681563 |
| 29 | Hyperglycinemia (HP:0002154) | 4.41541583 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 4.25738658 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22254736 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 4.21291922 |
| 33 | Ketosis (HP:0001946) | 4.19948144 |
| 34 | Fat malabsorption (HP:0002630) | 4.15689854 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12854881 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10781347 |
| 37 | Abnormality of complement system (HP:0005339) | 4.05877140 |
| 38 | Blue irides (HP:0000635) | 3.94228689 |
| 39 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.93739170 |
| 40 | Chronic bronchitis (HP:0004469) | 3.90064226 |
| 41 | Bronchiectasis (HP:0002110) | 3.89520743 |
| 42 | Increased circulating renin level (HP:0000848) | 3.89261448 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 3.87771309 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87771309 |
| 45 | Hyperglycinuria (HP:0003108) | 3.85635474 |
| 46 | Hypokalemic alkalosis (HP:0001949) | 3.84270987 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 3.84189219 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83245719 |
| 49 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.81204715 |
| 50 | Hypoglycemic coma (HP:0001325) | 3.80235368 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79145865 |
| 52 | Hypercholesterolemia (HP:0003124) | 3.71920737 |
| 53 | Retinal atrophy (HP:0001105) | 3.70932192 |
| 54 | Lip pit (HP:0100267) | 3.41540510 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.35571962 |
| 56 | Spontaneous abortion (HP:0005268) | 3.34060822 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26392708 |
| 58 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23058548 |
| 59 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 3.14294477 |
| 60 | Nasal polyposis (HP:0100582) | 3.13875949 |
| 61 | Delayed CNS myelination (HP:0002188) | 3.10161310 |
| 62 | Steatorrhea (HP:0002570) | 3.06193769 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 3.03247785 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02734562 |
| 65 | Myocardial infarction (HP:0001658) | 3.01114679 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 3.00810521 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 3.00074286 |
| 68 | Ketoacidosis (HP:0001993) | 2.96118780 |
| 69 | Polydipsia (HP:0001959) | 2.90274061 |
| 70 | Abnormal drinking behavior (HP:0030082) | 2.90274061 |
| 71 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.90028445 |
| 72 | Aplasia of the musculature (HP:0100854) | 2.85331787 |
| 73 | Skin nodule (HP:0200036) | 2.85247825 |
| 74 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.83005121 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.80229794 |
| 76 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.74624400 |
| 77 | Acanthocytosis (HP:0001927) | 2.74288886 |
| 78 | Metabolic acidosis (HP:0001942) | 2.69804826 |
| 79 | Glomerulonephritis (HP:0000099) | 2.69405691 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.64528910 |
| 81 | Chronic hepatic failure (HP:0100626) | 2.60191329 |
| 82 | Vascular calcification (HP:0004934) | 2.60183832 |
| 83 | Poikiloderma (HP:0001029) | 2.59751975 |
| 84 | Elbow flexion contracture (HP:0002987) | 2.59595127 |
| 85 | Lethargy (HP:0001254) | 2.54933126 |
| 86 | Depressed nasal tip (HP:0000437) | 2.54339562 |
| 87 | Thickened helices (HP:0000391) | 2.53223447 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.48800017 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48800017 |
| 90 | Abnormal gallbladder morphology (HP:0012437) | 2.47891547 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.47634119 |
| 92 | Abnormality of the periventricular white matter (HP:0002518) | 2.47485693 |
| 93 | Infertility (HP:0000789) | 2.46124838 |
| 94 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.46009935 |
| 95 | Spastic diplegia (HP:0001264) | 2.44876242 |
| 96 | Mitral stenosis (HP:0001718) | 2.43480261 |
| 97 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.41769052 |
| 98 | Gout (HP:0001997) | 2.41251754 |
| 99 | Cholelithiasis (HP:0001081) | 2.41233619 |
| 100 | Gingival bleeding (HP:0000225) | 2.38726918 |
| 101 | Abnormality of renin-angiotensin system (HP:0000847) | 2.37942459 |
| 102 | Tetany (HP:0001281) | 2.37803563 |
| 103 | Amyloidosis (HP:0011034) | 2.36984299 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36713776 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.36521202 |
| 106 | Cholecystitis (HP:0001082) | 2.36521202 |
| 107 | Abnormality of the nasal mucosa (HP:0000433) | 2.36511766 |
| 108 | Cerebral edema (HP:0002181) | 2.35795720 |
| 109 | Bronchitis (HP:0012387) | 2.35426753 |
| 110 | Irritability (HP:0000737) | 2.32460527 |
| 111 | Cardiovascular calcification (HP:0011915) | 2.30732684 |
| 112 | Neonatal onset (HP:0003623) | 2.28877011 |
| 113 | Esophageal varix (HP:0002040) | 2.27985829 |
| 114 | Spinal canal stenosis (HP:0003416) | 2.27947285 |
| 115 | Amblyopia (HP:0000646) | 2.25988424 |
| 116 | Male infertility (HP:0003251) | 2.25537613 |
| 117 | Abnormality of the 2nd finger (HP:0004100) | 2.25348250 |
| 118 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 2.23549720 |
| 119 | Malnutrition (HP:0004395) | 2.23330515 |
| 120 | Dyschromatopsia (HP:0007641) | 2.22346824 |
| 121 | Menorrhagia (HP:0000132) | 2.22111129 |
| 122 | Thrombophlebitis (HP:0004418) | 2.19616751 |
| 123 | Abnormality of the ischium (HP:0003174) | 2.18660083 |
| 124 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.16884480 |
| 125 | Fetal akinesia sequence (HP:0001989) | 2.14524770 |
| 126 | Poikilocytosis (HP:0004447) | 2.11595718 |
| 127 | Birth length less than 3rd percentile (HP:0003561) | 2.11559596 |
| 128 | Popliteal pterygium (HP:0009756) | 2.10829815 |
| 129 | 2-3 toe syndactyly (HP:0004691) | 2.10752598 |
| 130 | Pancreatitis (HP:0001733) | 2.10612475 |
| 131 | Abnormality of DNA repair (HP:0003254) | 2.10468565 |
| 132 | Sensorimotor neuropathy (HP:0007141) | 2.10279587 |
| 133 | Enlarged kidneys (HP:0000105) | 2.09026873 |
| 134 | Late onset (HP:0003584) | 2.08394623 |
| 135 | Brushfield spots (HP:0001088) | 2.05865555 |
| 136 | Hemorrhage of the eye (HP:0011885) | 2.02603649 |
| 137 | Abnormality of the pons (HP:0007361) | 2.01477393 |
| 138 | Vomiting (HP:0002013) | 2.01381316 |
| 139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00479978 |
| 140 | Abnormality of the gallbladder (HP:0005264) | 2.00173387 |
| 141 | Opisthotonus (HP:0002179) | 1.98624482 |
| 142 | Polyuria (HP:0000103) | 1.97986130 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.97438716 |
| 144 | Recurrent sinusitis (HP:0011108) | 1.97327096 |
| 145 | Submucous cleft hard palate (HP:0000176) | 1.92028108 |
| 146 | Rickets (HP:0002748) | 1.91322453 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.88905123 |
| 148 | Nephritis (HP:0000123) | 1.88479639 |
| 149 | Ragged-red muscle fibers (HP:0003200) | 1.88445265 |
| 150 | Progressive muscle weakness (HP:0003323) | 1.88226687 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86969179 |
| 152 | Hypophosphatemic rickets (HP:0004912) | 1.85469187 |
| 153 | Median cleft lip (HP:0000161) | 1.85201587 |
| 154 | Hypomagnesemia (HP:0002917) | 1.84546371 |
| 155 | Abnormality of the labia majora (HP:0012881) | 1.84022692 |
| 156 | Abnormal cartilage morphology (HP:0002763) | 1.82776234 |
| 157 | Oculomotor apraxia (HP:0000657) | 1.81957694 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80703938 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 1.80697137 |
| 160 | Hydroxyprolinuria (HP:0003080) | 1.80697137 |
| 161 | Renal cortical cysts (HP:0000803) | 1.80615154 |
| 162 | Microvesicular hepatic steatosis (HP:0001414) | 1.80481874 |
| 163 | Elevated hepatic transaminases (HP:0002910) | 1.80119522 |
| 164 | Alkalosis (HP:0001948) | 1.79957641 |
| 165 | Short chin (HP:0000331) | 1.78436779 |
| 166 | Status epilepticus (HP:0002133) | 1.78108890 |
| 167 | Hypoplasia of the pons (HP:0012110) | 1.77725617 |
| 168 | Accelerated skeletal maturation (HP:0005616) | 1.76397678 |
| 169 | Prominent nose (HP:0000448) | 1.75516733 |
| 170 | Paralysis (HP:0003470) | 1.74675734 |
| 171 | Hyperglycemia (HP:0003074) | 1.73866802 |
| 172 | Entropion (HP:0000621) | 1.73278591 |
| 173 | White forelock (HP:0002211) | 1.72796615 |
| 174 | Abnormality of homocysteine metabolism (HP:0010919) | 1.71524241 |
| 175 | Homocystinuria (HP:0002156) | 1.71524241 |
| 176 | Stroke (HP:0001297) | 1.71424203 |
| 177 | Pulmonary embolism (HP:0002204) | 1.70969469 |
| 178 | Sparse lateral eyebrow (HP:0005338) | 1.66141990 |
| 179 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.65803295 |
| 180 | Wide intermamillary distance (HP:0006610) | 1.64413954 |
| 181 | Abnormal urine output (HP:0012590) | 1.63823704 |
| 182 | Chronic sinusitis (HP:0011109) | 1.63503461 |
| 183 | Aplasia cutis congenita (HP:0001057) | 1.63442034 |
| 184 | Calcaneovalgus deformity (HP:0001848) | 1.63132166 |
| 185 | Premature graying of hair (HP:0002216) | 1.62395032 |
| 186 | Knee flexion contracture (HP:0006380) | 1.60660037 |
| 187 | Recurrent otitis media (HP:0000403) | 1.60136299 |
| 188 | Ulnar bowing (HP:0003031) | 1.60055136 |
| 189 | Round face (HP:0000311) | 1.58797575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.93800161 |
| 2 | WNK4 | 5.43381366 |
| 3 | STK39 | 4.92458559 |
| 4 | FGFR4 | 4.71373811 |
| 5 | SIK1 | 4.65488448 |
| 6 | ERN1 | 4.42645610 |
| 7 | OXSR1 | 3.71415262 |
| 8 | NEK6 | 3.34319400 |
| 9 | TAOK3 | 3.20752508 |
| 10 | INSRR | 3.11076713 |
| 11 | ACVR1B | 2.98561782 |
| 12 | ERBB4 | 2.96835850 |
| 13 | MAP2K4 | 2.35482379 |
| 14 | AKT3 | 2.33765944 |
| 15 | BRD4 | 2.30487363 |
| 16 | PKN2 | 2.21597805 |
| 17 | MST1R | 2.17895201 |
| 18 | PDK2 | 10.3577796 |
| 19 | MAPK11 | 1.91464973 |
| 20 | PIK3CG | 1.89151177 |
| 21 | FLT3 | 1.88893392 |
| 22 | BMPR1B | 1.83595930 |
| 23 | TYK2 | 1.76384620 |
| 24 | TRIB3 | 1.75509776 |
| 25 | LATS1 | 1.71439228 |
| 26 | DAPK2 | 1.56509358 |
| 27 | PTK6 | 1.49992538 |
| 28 | BRSK2 | 1.45735751 |
| 29 | ABL2 | 1.44599277 |
| 30 | FGFR2 | 1.43845728 |
| 31 | FRK | 1.42442609 |
| 32 | NEK9 | 1.39756861 |
| 33 | KDR | 1.36912086 |
| 34 | RAF1 | 1.27395957 |
| 35 | JAK2 | 1.26523868 |
| 36 | CAMKK2 | 1.24671602 |
| 37 | MAP3K7 | 1.23227746 |
| 38 | TLK1 | 1.18115104 |
| 39 | BMPR2 | 1.17862794 |
| 40 | PIM2 | 1.15928291 |
| 41 | PRKAA2 | 1.13723534 |
| 42 | JAK1 | 1.10287933 |
| 43 | PIM1 | 1.10098246 |
| 44 | ERBB2 | 1.08409082 |
| 45 | PINK1 | 1.08261166 |
| 46 | STK11 | 1.06603613 |
| 47 | CDK12 | 1.05146889 |
| 48 | GRK6 | 1.03027918 |
| 49 | MAP2K3 | 1.01514772 |
| 50 | TBK1 | 1.01094986 |
| 51 | MAPK4 | 1.00486498 |
| 52 | MAP3K10 | 0.99446564 |
| 53 | MAP3K14 | 0.97049701 |
| 54 | ZAK | 0.96192755 |
| 55 | EPHB1 | 0.94262419 |
| 56 | RPS6KB2 | 0.93280959 |
| 57 | PRKCZ | 0.91338590 |
| 58 | EPHA3 | 0.90381217 |
| 59 | MET | 0.88636945 |
| 60 | MELK | 0.87528931 |
| 61 | STK38L | 0.82714724 |
| 62 | TGFBR1 | 0.81005069 |
| 63 | CDK6 | 0.80450779 |
| 64 | MAPK12 | 0.79759171 |
| 65 | CAMK1D | 0.79513699 |
| 66 | MAP3K3 | 0.79389366 |
| 67 | TIE1 | 0.76899730 |
| 68 | PRKACG | 0.76643590 |
| 69 | MAPK15 | 0.74132583 |
| 70 | CSK | 0.71624875 |
| 71 | DYRK1B | 0.69662901 |
| 72 | MAP3K11 | 0.69326526 |
| 73 | CAMK2G | 0.68154465 |
| 74 | PRKAA1 | 0.67921747 |
| 75 | GSK3A | 0.67364820 |
| 76 | SGK3 | 0.65400945 |
| 77 | RIPK1 | 0.65135736 |
| 78 | FGFR3 | 0.64905349 |
| 79 | ERBB3 | 0.63945169 |
| 80 | MAP2K6 | 0.60518732 |
| 81 | CSF1R | 0.60274315 |
| 82 | MAPK7 | 0.59377556 |
| 83 | TGFBR2 | 0.58942276 |
| 84 | IRAK3 | 0.55398453 |
| 85 | BLK | 0.53599032 |
| 86 | PTK2 | 0.53470523 |
| 87 | IKBKE | 0.52102008 |
| 88 | EPHA4 | 0.50382523 |
| 89 | PRKCQ | 0.49914486 |
| 90 | SGK2 | 0.48942374 |
| 91 | PDPK1 | 0.48001031 |
| 92 | CDK8 | 0.46671033 |
| 93 | CSNK1G1 | 0.46005096 |
| 94 | GRK1 | 0.45142103 |
| 95 | RET | 0.44720686 |
| 96 | IGF1R | 0.44497643 |
| 97 | MAP3K5 | 0.43973484 |
| 98 | PKN1 | 0.42111987 |
| 99 | ATR | 0.42052264 |
| 100 | MAP3K13 | 0.41263615 |
| 101 | PRKCG | 0.40054977 |
| 102 | MAP2K1 | 0.39524892 |
| 103 | TAOK2 | 0.39449565 |
| 104 | CDK4 | 0.39443246 |
| 105 | YES1 | 0.38912627 |
| 106 | MAP3K2 | 0.38039543 |
| 107 | ICK | 0.37971815 |
| 108 | MTOR | 0.37184071 |
| 109 | WNK1 | 0.35544252 |
| 110 | MAP3K6 | 0.35330879 |
| 111 | EGFR | 0.34642409 |
| 112 | SGK223 | 0.33657529 |
| 113 | SGK494 | 0.33657529 |
| 114 | MAP2K2 | 0.32601393 |
| 115 | TRPM7 | 0.32437658 |
| 116 | CAMK1G | 0.32005959 |
| 117 | TEC | 0.31911200 |
| 118 | TXK | 0.31868909 |
| 119 | MST4 | 0.31810532 |
| 120 | SGK1 | 0.31567758 |
| 121 | CAMK4 | 0.31423659 |
| 122 | SMG1 | 0.30772460 |
| 123 | SRPK1 | 0.30582676 |
| 124 | NUAK1 | 0.30529826 |
| 125 | IRAK1 | 0.29964178 |
| 126 | PDK1 | 0.29845906 |
| 127 | MAPK1 | 0.29776807 |
| 128 | CHEK2 | 0.29583617 |
| 129 | JAK3 | 0.29046660 |
| 130 | RPS6KA5 | 0.28558859 |
| 131 | PTK2B | 0.28212310 |
| 132 | MAPK10 | 0.27857805 |
| 133 | CHEK1 | 0.27413305 |
| 134 | MAP3K1 | 0.27296852 |
| 135 | PBK | 0.27159130 |
| 136 | MAPK8 | 0.26335698 |
| 137 | LATS2 | 0.26214270 |
| 138 | FES | 0.25584835 |
| 139 | PRKCA | 0.24902649 |
| 140 | MKNK2 | 0.24767954 |
| 141 | CDK2 | 0.24648105 |
| 142 | CSNK1G2 | 0.23762738 |
| 143 | IRAK2 | 0.23260297 |
| 144 | ADRBK1 | 0.22669785 |
| 145 | EEF2K | 0.22625388 |
| 146 | ABL1 | 0.22316325 |
| 147 | MAPK3 | 0.22218030 |
| 148 | GSK3B | 0.22182801 |
| 149 | PAK3 | 0.21912532 |
| 150 | NLK | 0.21267885 |
| 151 | PIK3CA | 0.20592511 |
| 152 | PDGFRB | 0.20380536 |
| 153 | BMX | 0.19538113 |
| 154 | CSNK1G3 | 0.19083369 |
| 155 | MAPK14 | 0.18858660 |
| 156 | PRKACB | 0.18138433 |
| 157 | AKT1 | 0.17645033 |
| 158 | RPS6KB1 | 0.17588244 |
| 159 | BTK | 0.17055879 |
| 160 | AURKB | 0.16689731 |
| 161 | PRKACA | 0.16525634 |
| 162 | CAMKK1 | 0.15774816 |
| 163 | ATM | 0.15553899 |
| 164 | STK38 | 0.15224052 |
| 165 | PLK1 | 0.14319591 |
| 166 | CDK1 | 0.14034069 |
| 167 | MARK2 | 0.13618626 |
| 168 | ITK | 0.13136531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48615540 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.79819038 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39617414 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36735907 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07925637 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.88320482 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71964574 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65566390 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62035056 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53427025 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47316495 |
| 12 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.37729487 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35512297 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25508975 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15004230 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10666859 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.04246332 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92267412 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92210892 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91233101 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90035798 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88995762 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88413709 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85136543 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80639995 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77753535 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75505095 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70861216 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68946663 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68744840 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66758200 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.65464716 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61860979 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60198437 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58809778 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55007207 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.51197743 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.51133804 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49632184 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48463929 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42545504 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.42051718 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35809860 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33864977 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30533572 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30074920 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29884331 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28843313 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25811966 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.25448018 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.24973232 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23386758 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19693192 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16748301 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16224912 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16129911 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11473257 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 1.04081394 |
| 59 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.02738886 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01593908 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01002578 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99271137 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98330292 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97431841 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94182844 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93943614 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91789659 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.91240985 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89206924 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88102579 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85922980 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85646496 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82310473 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.81482329 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77590696 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77300645 |
| 77 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.73080606 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71167045 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69053255 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67085721 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.64335200 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63594646 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60848349 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60752077 |
| 85 | Cell cycle_Homo sapiens_hsa04110 | 0.60288488 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.59387429 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57446347 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56723491 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55021740 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53129868 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49048401 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47892254 |
| 93 | Mismatch repair_Homo sapiens_hsa03430 | 0.47485176 |
| 94 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46133586 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45613162 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44688835 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43326669 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41881285 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41591409 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41409151 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39487787 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39391193 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38650531 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37152239 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.35493514 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33183131 |
| 107 | DNA replication_Homo sapiens_hsa03030 | 0.29372468 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29020627 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.28987102 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27837587 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.27429524 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27414621 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25436405 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.24822455 |
| 115 | Spliceosome_Homo sapiens_hsa03040 | 0.24209281 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24113739 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23843696 |
| 118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.23687726 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21983418 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20816611 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.20549508 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20485894 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20231033 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15243322 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10842112 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02778755 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | -0.2383267 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2348779 |
| 129 | Pertussis_Homo sapiens_hsa05133 | -0.2347861 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2265581 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2186636 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1937766 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1902782 |
| 134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1873632 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1815319 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1801620 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | -0.1674198 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1557199 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1540263 |
| 140 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1451043 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1442950 |
| 142 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1173819 |
| 143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0948319 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0943413 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0687007 |
| 146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0659729 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0659011 |

